"Precision Medicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.
| Descriptor ID |
D057285
|
| MeSH Number(s) |
E02.574 H02.403.200.700
|
| Concept/Terms |
Precision Medicine- Precision Medicine
- Medicine, Precision
- Personalized Medicine
- Medicine, Personalized
- Individualized Medicine
- Medicine, Individualized
|
Below are MeSH descriptors whose meaning is more general than "Precision Medicine".
Below are MeSH descriptors whose meaning is more specific than "Precision Medicine".
This graph shows the total number of publications written about "Precision Medicine" by people in this website by year, and whether "Precision Medicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 7 | 3 | 10 |
| 2012 | 2 | 4 | 6 |
| 2013 | 4 | 3 | 7 |
| 2014 | 3 | 3 | 6 |
| 2015 | 13 | 10 | 23 |
| 2016 | 21 | 13 | 34 |
| 2017 | 9 | 3 | 12 |
| 2018 | 11 | 13 | 24 |
| 2019 | 10 | 10 | 20 |
| 2020 | 8 | 10 | 18 |
| 2021 | 4 | 10 | 14 |
| 2022 | 7 | 12 | 19 |
| 2023 | 5 | 13 | 18 |
| 2024 | 11 | 2 | 13 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precision Medicine" by people in Profiles.
-
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
-
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):387-402.
-
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials. Ann Surg Oncol. 2025 Apr; 32(4):2777-2785.
-
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials. J Clin Oncol. 2025 Feb 20; 43(6):735-747.
-
Leveraging human microbiomes for disease prediction and treatment. Trends Pharmacol Sci. 2025 Jan; 46(1):32-44.
-
Health equity innovation in precision medicine: data stewardship and agency to expand representation in clinicogenomics. Health Res Policy Syst. 2024 Dec 19; 22(1):170.
-
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma. Ann Oncol. 2025 Apr; 36(4):426-443.
-
Redefining pancreatic cancer management with tumor-agnostic precision medicine. Carcinogenesis. 2024 Nov 22; 45(11):836-844.
-
A novel statistical framework for meta-analysis of total mediation effect with high-dimensional omics mediators in large-scale genomic consortia. PLoS Genet. 2024 Nov; 20(11):e1011483.
-
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review. Curr Oncol Rep. 2024 Dec; 26(12):1612-1638.